Intra-Cellular Therapies, Inc.
NASDAQ:ITCI
90.51 (USD) • At close November 7, 2024
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | ||||||||||||
| Nettowinst
| -139.674 | -256.256 | -284.126 | -227.006 | -147.722 | -155.127 | -97.773 | -116.426 | -104.793 | -30.691 | -26.868 | -16.591 |
| Afschrijvingen & Amortisatie
| 0.528 | 0.656 | 0.533 | 0.528 | 0.477 | 0.369 | 0.214 | 0.197 | 0.14 | 0.025 | 0.023 | 0.048 |
| Uitgestelde Inkomstenbelasting
| -8.4 | 0 | -4.08 | -0.648 | -1.132 | 529.217 | -1,058.435 | 0.544 | 0.713 | 0.297 | -0.391 | 0 |
| Aandelen Gebaseerde Vergoedingen
| 52.832 | 43.013 | 34.303 | 24.115 | 20.789 | 17.396 | 14.642 | 14.701 | 10.891 | 3.844 | 0.391 | 0.295 |
| Verandering in Werkkapitaal
| -29.577 | -58.136 | -6.353 | -27.276 | -0.589 | 19.944 | 1.805 | 9.493 | -9.413 | 3.542 | 3.862 | -2.655 |
| Vorderingen
| -38.829 | -55.033 | -9.391 | -10.765 | 0 | 0 | 0.094 | -0.064 | 0.021 | 0.285 | -0.036 | 0.049 |
| Voorraden
| -26.348 | -15.972 | -0.892 | -7.056 | 0 | 0 | 0.332 | 6.163 | -10.611 | 0 | 2.211 | -0.483 |
| Crediteuren
| 1.057 | 1.704 | 3.189 | -1.923 | -6.536 | 7.788 | 2.419 | 2.122 | -0.42 | -1.342 | 3.353 | -0.554 |
| Overig Werkkapitaal
| 34.543 | 11.165 | 0.741 | -7.532 | 5.947 | 12.157 | -1.04 | 1.272 | 1.597 | 4.599 | -1.667 | -1.667 |
| Overige Niet-Contante Posten
| 0.092 | 0.537 | 0.179 | 0.214 | 0.194 | -529.968 | 1,059.056 | 0.234 | 0.183 | 0.176 | 0.391 | -2.36 |
| Kasstroom uit Operationele Activiteiten
| -124.199 | -270.186 | -259.543 | -230.073 | -127.983 | -118.169 | -80.492 | -91.257 | -102.28 | -22.807 | -22.591 | -18.903 |
| Investeringsactiviteiten: | ||||||||||||
| Investeringen in Materiële Vaste Activa
| -0.269 | -0.778 | -0.326 | -0.267 | -0.7 | -0.391 | -0.723 | -0.049 | -0.861 | -0.012 | -0.033 | -0.039 |
| Netto Overnames
| 0 | 127.595 | -280.669 | 480.028 | -178.137 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Aankoop van Beleggingen
| -415.269 | -759.209 | -224.575 | -755.63 | -80.72 | -271.157 | -520.927 | -395.757 | -514.308 | -103.602 | 0 | -12 |
| Verkoop/verval van Beleggingen
| 521.079 | 631.614 | 505.244 | 275.601 | 258.858 | 406.189 | 428.933 | 488.069 | 153.389 | 36.879 | 1.5 | 17.7 |
| Overige Investeringsactiviteiten
| 105.81 | -127.595 | 280.669 | -480.028 | 178.137 | 135.033 | -91.994 | 92.311 | -360.919 | -66.723 | 1.5 | 5.7 |
| Kasstroom uit Investeringsactiviteiten
| 105.541 | -128.373 | 280.344 | -480.295 | 177.437 | 134.641 | -92.718 | 92.262 | -361.779 | -66.734 | 1.467 | 5.661 |
| Financieringsactiviteiten: | ||||||||||||
| Schuldaflossingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -125 | 0 | 0 | 0 | 0 |
| Uitgifte van Gewone Aandelen
| 17.81 | 455.159 | 11.519 | 652.712 | 3.236 | 0.685 | 162.15 | 233.772 | 449.894 | 116.191 | 43.842 | 0 |
| Terugkoop van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3.755 | 0 |
| Uitgekeerde Dividenden
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Financieringsactiviteiten
| 17.81 | 455.159 | 11.519 | 11.465 | 3.236 | 0.685 | 0.207 | -108.294 | 449.894 | -0.476 | 40.63 | 15.194 |
| Kasstroom uit Financieringsactiviteiten
| 17.81 | 455.159 | 11.519 | 664.177 | 3.236 | 0.685 | 162.357 | 0.478 | 449.894 | 115.716 | 40.63 | 15.194 |
| Overige Informatie: | ||||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Netto Kasstroomverandering
| -0.848 | 56.6 | 32.319 | -46.191 | 52.689 | 17.157 | -10.852 | 1.483 | -14.166 | 26.174 | 19.505 | 1.952 |
| Kaspositie aan het Einde van de Periode
| 149.517 | 150.365 | 93.765 | 61.446 | 107.637 | 54.948 | 37.79 | 48.642 | 47.159 | 61.325 | 35.151 | 15.646 |